Port FK - Search Results

1

Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival.

Leypoldt JK, Cheung AK, Carroll CE, Stannard DC, Pereira BJ, Agodoa LY, Port FK. Leypoldt JK, et al. Among authors: port fk. Am J Kidney Dis. 1999 Feb;33(2):349-55. doi: 10.1016/s0272-6386(99)70311-2. Am J Kidney Dis. 1999. PMID: 10023649

2

Regional Differences in the Associations Between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the Dialysis Outcomes and Practice Patterns Study.

Hecking M, Wong MMY, Port FK, Robinson BM, McCullough KP. Hecking M, et al. Among authors: port fk. Am J Kidney Dis. 2017 Sep;70(3):450-451. doi: 10.1053/j.ajkd.2017.03.024. Epub 2017 May 24. Am J Kidney Dis. 2017. PMID: 28549537 No abstract available.

3

Survival advantage in Asian American end-stage renal disease patients.

Wong JS, Port FK, Hulbert-Shearon TE, Carroll CE, Wolfe RA, Agodoa LY, Daugirdas JT. Wong JS, et al. Among authors: port fk. Kidney Int. 1999 Jun;55(6):2515-23. doi: 10.1046/j.1523-1755.1999.00464.x. Kidney Int. 1999. PMID: 10354301

4

Renal transplantation in end-stage sickle cell nephropathy.

Ojo AO, Govaerts TC, Schmouder RL, Leichtman AB, Leavey SF, Wolfe RA, Held PJ, Port FK, Agodoa LY. Ojo AO, et al. Among authors: port fk. Transplantation. 1999 Jan 27;67(2):291-5. doi: 10.1097/00007890-199901270-00018. Transplantation. 1999. PMID: 10075596

5

Differences in the patterns of age-specific black/white comparisons between end-stage renal disease attributed and not attributed to diabetes.

Lopes AA, Port FK. Lopes AA, et al. Among authors: port fk. Am J Kidney Dis. 1995 May;25(5):714-21. doi: 10.1016/0272-6386(95)90547-2. Am J Kidney Dis. 1995. PMID: 7747725

6

Analysis of survival of end-stage renal disease patients.

Weller JM, Port FK, Swartz RD, Ferguson CW, Williams GW, Jacobs JF Jr. Weller JM, et al. Among authors: port fk. Kidney Int. 1982 Jan;21(1):78-83. doi: 10.1038/ki.1982.11. Kidney Int. 1982. PMID: 7043052

7

Recovery from end-stage renal disease.

Sekkarie MA, Port FK, Wolfe RA, Guire K, Humphrys R, Van Amburg G, Ferguson CW. Sekkarie MA, et al. Among authors: port fk. Am J Kidney Dis. 1990 Jan;15(1):61-5. doi: 10.1016/s0272-6386(12)80593-2. Am J Kidney Dis. 1990. PMID: 2294734

8

Characteristics and treatment of patients not reusing dialyzers in reuse units.

Okechukwu CN, Orzol SM, Held PJ, Pereira BJ, Agodoa LY, Wolfe RA, Port FK. Okechukwu CN, et al. Among authors: port fk. Am J Kidney Dis. 2000 Nov;36(5):991-9. doi: 10.1053/ajkd.2000.19101. Am J Kidney Dis. 2000. PMID: 11054356

9

Vascular access survival among incident hemodialysis patients in the United States.

Woods JD, Turenne MN, Strawderman RL, Young EW, Hirth RA, Port FK, Held PJ. Woods JD, et al. Among authors: port fk. Am J Kidney Dis. 1997 Jul;30(1):50-7. doi: 10.1016/s0272-6386(97)90564-3. Am J Kidney Dis. 1997. PMID: 9214401

10

[DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in Spain].

Piera L, Cruz JM, Braga-Gresham JL, Eichleay MA, Pisoni RL, Port FK. Piera L, et al. Among authors: port fk. Nefrologia. 2007;27(4):496-504. Nefrologia. 2007. PMID: 17944588 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results